(Q43823432)

27 November 2017

title

Blunted sympathetic response in diabetic patients with decompensated congestive heart failure (English)

1 reference

27 November 2017

main subject

congestive heart failure

1 reference

Burger AJ

1

1 reference

27 November 2017

Aronson D

series ordinal

2

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

International Journal of Cardiology

27 November 2017

published in

1 reference

27 November 2017

volume

81

1 reference

27 November 2017

issue

2-3

1 reference

27 November 2017

page(s)

243-249

1 reference

Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Role of diabetes in congestive heart failure: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Plasma Catecholamines in Long-Term Diabetics with and without Neuropathy and in Hypophysectomized Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Cardiovascular responses to graded reductions of central blood volume in normal subjects and in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

A sensitive sandwich-enzyme immunoassay for human endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Diabetic and hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Endothelin: emerging role in diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Impaired responses of catecholamines, growth hormone, and cortisol to graded exercise in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Adrenergic nervous system in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900573-3

7 January 2021

10.1016/S0167-5273(01)00573-3

Identifiers

DOI

1 reference

27 November 2017

1 reference